Esperion Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $111k | 37k | 2.99 |
| 2023-06-30 | $22k | 16k | 1.39 |
| 2023-03-31 | $7.6M | 4.8M | 1.59 |
| 2022-12-31 | $21M | 3.4M | 6.23 |
| 2022-09-30 | $5.3M | 796k | 6.70 |
| 2022-06-30 | $76k | 12k | 6.35 |
| 2020-09-30 | $3.7M | 100k | 37.17 |
| 2020-06-30 | $3.2M | 62k | 51.32 |
| 2020-03-31 | $9.8M | 312k | 31.54 |
| 2019-12-31 | $22M | 375k | 59.63 |
| 2019-09-30 | $5.0M | 135k | 36.66 |
| 2019-06-30 | $7.5M | 161k | 46.52 |
| 2018-12-31 | $5.0M | 108k | 46.00 |
| 2018-09-30 | $439k | 9.9k | 44.37 |
| 2018-06-30 | $1.6M | 41k | 39.20 |
| 2018-03-31 | $11M | 150k | 72.33 |
| 2017-12-31 | $27M | 403k | 65.84 |
| 2017-09-30 | $20M | 393k | 50.12 |
| 2017-06-30 | $16M | 341k | 46.28 |
| 2017-03-31 | $1.7M | 50k | 35.31 |